Weidinger C - Search Results

1

Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic Targets.

Weidinger C, Krug SM, Voskens C, Moschen AR, Atreya I. Weidinger C, et al. Front Med (Lausanne). 2021 Dec 9;8:813153. doi: 10.3389/fmed.2021.813153. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34957170 Free PMC article. No abstract available.

2

Anti-Adhesion Therapies in Inflammatory Bowel Disease-Molecular and Clinical Aspects.

Zundler S, Becker E, Weidinger C, Siegmund B. Zundler S, et al. Among authors: weidinger c. Front Immunol. 2017 Jul 28;8:891. doi: 10.3389/fimmu.2017.00891. eCollection 2017. Front Immunol. 2017. PMID: 28804488 Free PMC article. Review.

3

Metabolic Control of Epigenetics and Its Role in CD8⁺ T Cell Differentiation and Function.

Yerinde C, Siegmund B, Glauben R, Weidinger C. Yerinde C, et al. Among authors: weidinger c. Front Immunol. 2019 Nov 26;10:2718. doi: 10.3389/fimmu.2019.02718. eCollection 2019. Front Immunol. 2019. PMID: 31849941 Free PMC article. Review.

4

Functional Role of Transient Receptor Potential Channels in Immune Cells and Epithelia.

Khalil M, Alliger K, Weidinger C, Yerinde C, Wirtz S, Becker C, Engel MA. Khalil M, et al. Among authors: weidinger c. Front Immunol. 2018 Feb 7;9:174. doi: 10.3389/fimmu.2018.00174. eCollection 2018. Front Immunol. 2018. PMID: 29467763 Free PMC article. Review.

5

The role of adipose tissue in inflammatory bowel diseases.

Weidinger C, Hegazy AN, Siegmund B. Weidinger C, et al. Curr Opin Gastroenterol. 2018 Jul;34(4):183-186. doi: 10.1097/MOG.0000000000000445. Curr Opin Gastroenterol. 2018. PMID: 29846262 Review.

6

Adipokines and Their Role in Intestinal Inflammation.

Weidinger C, Ziegler JF, Letizia M, Schmidt F, Siegmund B. Weidinger C, et al. Front Immunol. 2018 Oct 12;9:1974. doi: 10.3389/fimmu.2018.01974. eCollection 2018. Front Immunol. 2018. PMID: 30369924 Free PMC article. Review.

7

Targeting SOCE in Intestinal Epithelial Cells: A New Treatment Concept for Inflammatory Bowel Disease?

Glauben R, Letizia M, Weidinger C. Glauben R, et al. Among authors: weidinger c. Cell Mol Gastroenterol Hepatol. 2022;14(1):243-244. doi: 10.1016/j.jcmgh.2022.04.008. Epub 2022 May 4. Cell Mol Gastroenterol Hepatol. 2022. PMID: 35523355 Free PMC article. No abstract available.

8

Store-operated calcium entry controls innate and adaptive immune cell function in inflammatory bowel disease.

Letizia M, Wang YH, Kaufmann U, Gerbeth L, Sand A, Brunkhorst M, Weidner P, Ziegler JF, Böttcher C, Schlickeiser S, Fernández C, Yamashita M, Stauderman K, Sun K, Kunkel D, Prakriya M; IBDome Researchers; Sanders A, Siegmund B, Feske S, Weidinger C. Letizia M, et al. Among authors: weidinger c. EMBO Mol Med. 2022 Sep 7;14(9):e15687. doi: 10.15252/emmm.202215687. Epub 2022 Aug 2. EMBO Mol Med. 2022. PMID: 35919953 Free PMC article.

9

Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells.

Wu H, Weidinger C, Schmidt F, Keye J, Friedrich M, Yerinde C, Willimsky G, Qin Z, Siegmund B, Glauben R. Wu H, et al. Among authors: weidinger c. Sci Rep. 2017 Aug 8;7(1):7498. doi: 10.1038/s41598-017-07685-9. Sci Rep. 2017. PMID: 28790345 Free PMC article.

10

HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation.

Friedrich M, Gerbeth L, Gerling M, Rosenthal R, Steiger K, Weidinger C, Keye J, Wu H, Schmidt F, Weichert W, Siegmund B, Glauben R. Friedrich M, et al. Among authors: weidinger c. Mucosal Immunol. 2019 May;12(3):656-667. doi: 10.1038/s41385-019-0135-7. Epub 2019 Jan 23. Mucosal Immunol. 2019. PMID: 30674988 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page